Kirsch on anti-depressants vs placebo 09/09/2013 Michael Doneman Irving Kirsch, of theĀ Program in Placebo Studies & Therapeutic Encounter at Harvard Medical School, comments once more on the use (and the marketing) of anti-depressants, an enormous moneyspinner for the big drug companies.